Literature DB >> 7473069

Histopathological effects of acute exposure to chlorine gas on Sprague-Dawley rat lungs.

R Demnati1, R Fraser, G Plaa, J L Malo.   

Abstract

It is now recognized that acute inhalational exposure to irritant gases such as chlorine can cause an asthma-like abnormality known as reactive airways dysfunction syndrome (RADS). The aim of this study was to evaluate the effects of exposure to various levels of chlorine on airway mucosa and lung parenchyma in an attempt to develop an animal model of this syndrome. Seventy-four Sprague-Dawley rats were exposed to air (controls) or to 50, 100, 200, 500, and 1500 ppm of chlorine for 2 to 10 min. Histological assessment was performed at 1, 3, 6, 12, 24, and 72 h after exposure. The results show that exposure to low concentrations (500 ppm) did not induce significant histological changes. Exposure to 1500 ppm for 2 min induced perivascular edema and the appearance of focal mild inflammation, whereas exposure to the same concentration for 10 min caused profound histological changes, including (1) 1 h: airspace and interstitial edema associated with bronchial epithelial sloughing; (2) 6 to 24 h: decreased edema and the appearance of mucosal polymorphonuclear leukocytes, maximal at 12 h; (3) 72 h: epithelial regeneration, manifested by hyperplasia and goblet cell metaplasia. We conclude that acute exposure to chlorine at a concentration of 1500 ppm for 10 min induces significant airway mucosal abnormalities that vary over a short period of time. Whether these abnormalities are related to the subsequent development of RADS awaits further experiments.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473069

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  8 in total

1.  Post-exposure antioxidant treatment in rats decreases airway hyperplasia and hyperreactivity due to chlorine inhalation.

Authors:  Michelle V Fanucchi; Andreas Bracher; Stephen F Doran; Giuseppe L Squadrito; Solana Fernandez; Edward M Postlethwait; Larry Bowen; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2011-12-08       Impact factor: 6.914

Review 2.  Role of heme in bromine-induced lung injury.

Authors:  Adam Lam; Nilam Vetal; Sadis Matalon; Saurabh Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2016-05-31       Impact factor: 5.691

3.  Heme Attenuation Ameliorates Irritant Gas Inhalation-Induced Acute Lung Injury.

Authors:  Saurabh Aggarwal; Adam Lam; Subhashini Bolisetty; Matthew A Carlisle; Amie Traylor; Anupam Agarwal; Sadis Matalon
Journal:  Antioxid Redox Signal       Date:  2015-12-14       Impact factor: 8.401

4.  Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine.

Authors:  C Leroyer; J L Malo; D Girard; J G Dufour; D Gautrin
Journal:  Occup Environ Med       Date:  1999-05       Impact factor: 4.402

Review 5.  Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models.

Authors:  Carl W White; James G Martin
Journal:  Proc Am Thorac Soc       Date:  2010-07

6.  Dimethylthiourea protects against chlorine induced changes in airway function in a murine model of irritant induced asthma.

Authors:  Toby K McGovern; William S Powell; Brian J Day; Carl W White; Karuthapillai Govindaraju; Harry Karmouty-Quintana; Normand Lavoie; Ju Jing Tan; James G Martin
Journal:  Respir Res       Date:  2010-10-06

7.  Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants.

Authors:  Martin Leustik; Stephen Doran; Andreas Bracher; Shawn Williams; Giuseppe L Squadrito; Trenton R Schoeb; Edward Postlethwait; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-15       Impact factor: 5.464

8.  Time course of airway remodelling after an acute chlorine gas exposure in mice.

Authors:  Stephanie A Tuck; David Ramos-Barbón; Holly Campbell; Toby McGovern; Harry Karmouty-Quintana; James G Martin
Journal:  Respir Res       Date:  2008-08-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.